Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study von Bible, Keith C, Dr, Suman, Vera J, Prof, Molina, Julian R, MD, Smallridge, Robert C, Prof, Maples, William J, MD, Menefee, Michael E, MD, Rubin, Joseph, Prof, Sideras, Kostandinos, MD, Morris, John C, MD, McIver, Bryan, MB, Burton, Jill K, Webster, Kevin P, Bieber, Carolyn, Traynor, Anne M, MD, Flynn, Patrick J, MD, Goh, Boon Cher, MBBS, Tang, Hui, PhD, Ivy, Susan Percy, MD, Erlichman, Charles, Prof

Volltext

The role of bail and pretrial detention in the reproduction of racial inequalities von Menefee, Michael R.

Volltext

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncolo... von Cabanillas, Maria E, de Souza, Jonas A, Geyer, Susan, Wirth, Lori J, Menefee, Michael E, Liu, Stephen V, Shah, Komal, Wright, John, Shah, Manisha H

Volltext

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer von Bible, Keith C, Suman, Vera J, Menefee, Michael E, Smallridge, Robert C, Molina, Julian R, Maples, William J, Karlin, Nina J, Traynor, Anne M, Kumar, Priya, Goh, Boon Cher, Lim, Wan-Teck, Bossou, Ayoko R, Isham, Crescent R, Webster, Kevin P, Kukla, Andrea K, Bieber, Carolyn, Burton, Jill K, Harris, Pamela, Erlichman, Charles, the Mayo Phase 2 Consortium and Mayo Clinic Endocrine Malignances Disease Oriented Group

Volltext

The Effect of Split Sentences on Employment and Future Criminal Justice Involvement: Evidence from a Natural Experiment von Menefee, Michael R, Harding, David J, Nguyen, Anh P, Morenoff, Jeffrey D, Bushway, Shawn D

Volltext

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors von Wahner Hendrickson, Andrea E, Menefee, Michael E, Hartmann, Lynn C, Long, Harry J, Northfelt, Donald W, Reid, Joel M, Boakye-Agyeman, Felix, Kayode, Olumide, Flatten, Karen S, Harrell, Maria I, Swisher, Elizabeth M, Poirier, Guy G, Satele, Daniel, Allred, Jake, Lensing, Janet L, Chen, Alice, Ji, Jiuping, Zang, Yiping, Erlichman, Charles, Haluska, Paul, Kaufmann, Scott H

Volltext

Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy von Iñiguez-Ariza, Nicole M, Jasim, Sina, Ryder, Mabel M, Chintakuntlawar, Ashish V, Morris, John C, Hilger, Crystal R, Menefee, Michael E, Smallridge, Robert C, Karlin, Nina J, Alcaino, Constanza, Bible, Keith C

Volltext

A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H von Bible, Keith C, Suman, Vera J, Molina, Julian R, Smallridge, Robert C, Maples, William J, Menefee, Michael E, Rubin, Joseph, Karlin, Nina, Sideras, Kostandinos, Morris, John C, McIver, Bryan, Hay, Ian, Fatourechi, Vahab, Burton, Jill K, Webster, Kevin P, Bieber, Carolyn, Traynor, Anne M, Flynn, Patrick J, Cher Goh, Boon, Isham, Crescent R, Harris, Pamela, Erlichman, Charles

Volltext

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma von Xie, Hao, Yin, Jun, Shah, Manisha H., Menefee, Michael E., Bible, Keith C., Reidy-Lagunes, Diane, Kane, Madeleine A., Quinn, David I., Gandara, David R., Erlichman, Charles, Adjei, Alex A.

Volltext

Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers von Cooper, Simon J, von Roemeling, Christina A, Kang, Kylie H, Marlow, Laura A, Grebe, Stefan K, Menefee, Michael E, Tun, Han W, Colon-Otero, Gerardo, Perez, Edith A, Copland, John A

Volltext

An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer von Bible, Keith C, Menefee, Michael E, Lin, Chia-Chi Josh, Millward, Michael J, Maples, William J, Goh, Boon Cher, Karlin, Nina J, Kane, Madeleine A, Adkins, Douglas R, Molina, Julian R, Donehower, Ross C, Lim, Wan-Teck, Flynn, Patrick J, Richardson, Ronald L, Traynor, Anne M, Rubin, Joseph, LoRusso, Patricia M, Smallridge, Robert C, Burton, Jill K, Suman, Vera J, Kumar, Aditi, Voss, Jessie S, Rumilla, Kandalaria M, Kipp, Benjamin R, Chintakuntlawar, Ashish V, Harris, Pamela, Erlichman, Charles

Volltext

Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib von Sideras, Kostandinos, Menefee, Michael E, Burton, Jill K, Erlichman, Charles, Bible, Keith C, Ivy, S Percy

Volltext

Present and future suitable habitat for the black-tailed prairie dog ecosystem von Davidson, Ana D., Fink, Michelle, Menefee, Michael, Sterling-Krank, Lindsey, Van Pelt, William, Augustine, David J.

Volltext

Organizational life cycle and performance among SMEs: Generic strategies for high and low performers von Lester, Donald L, Parnell, John A, Crandall, William "Rick", Menefee, Michael L

Volltext

Mixed response to immunotherapy in lung cancer von Baldeo, Candice, Kaleem, Tasneem, Paz-Fumagalli, Ricardo, Copland, John A., Menefee, Michael E.

Volltext

Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma von von Roemeling, Christina A, Marlow, Laura A, Kennedy, William P, Kennedy, Gregory T, Copland, John A, Menefee, Michael E

Volltext

Project Switch: Docetaxel as a potential synthetic control in metastatic non-small cell lung cancer (mNSCLC) trials von Menefee, Michael E., Gong, Yutao, Mishra-Kalyani, Pallavi Shruti, Sridhara, Rajeshwari, Kanapuru, Bindu, Blumenthal, Gideon Michael, Pazdur, Richard

Volltext

Strategy as a response to organizational uncertainty: an alternative perspective on the strategy-performance relationship von Parnell, John A, Lester, Donald L, Menefee, Michael L

Volltext

Systemic Therapeutic Approaches to Advanced Thyroid Cancers von Menefee, Michael E., Smallridge, Robert C., Bible, Keith C.

Volltext

Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors von Haluska, Paul, Menefee, Michael, Plimack, Elizabeth R, Rosenberg, Jonathan, Northfelt, Donald, LaVallee, Theresa, Shi, Li, Yu, Xiang-Qing, Burke, Patricia, Huang, Jiaqi, Huang, Jaiqi, Viner, Jaye, McDevitt, Jennifer, LoRusso, Patricia

Volltext